These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34157915)

  • 1. Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities.
    Abdel-Mageed HM; AbuelEzz NZ; Radwan RA; Mohamed SA
    J Microencapsul; 2021 Sep; 38(6):414-436. PubMed ID: 34157915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic formulation of nanoparticles for biomedical applications.
    Shepherd SJ; Issadore D; Mitchell MJ
    Biomaterials; 2021 Jul; 274():120826. PubMed ID: 33965797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
    Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
    Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles for multimodal imaging and theragnosis.
    Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
    Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery.
    Biffi S; Voltan R; Rampazzo E; Prodi L; Zauli G; Secchiero P
    Expert Opin Drug Deliv; 2015; 12(12):1837-49. PubMed ID: 26289673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicines accessible in the market for clinical interventions.
    Gadekar V; Borade Y; Kannaujia S; Rajpoot K; Anup N; Tambe V; Kalia K; Tekade RK
    J Control Release; 2021 Feb; 330():372-397. PubMed ID: 33370576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.
    Doane TL; Burda C
    Chem Soc Rev; 2012 Apr; 41(7):2885-911. PubMed ID: 22286540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook.
    Singh N; Shi S; Goel S
    Adv Drug Deliv Rev; 2023 Jan; 192():114638. PubMed ID: 36462644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.
    Waheed S; Li Z; Zhang F; Chiarini A; Armato U; Wu J
    J Nanobiotechnology; 2022 Aug; 20(1):395. PubMed ID: 36045386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation.
    Taha MS; Padmakumar S; Singh A; Amiji MM
    Drug Deliv Transl Res; 2020 Jun; 10(3):766-790. PubMed ID: 32170656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.